Collier A C
Clinical Trials Unit, University of Washington, Seattle, USA.
Adv Exp Med Biol. 1996;394:355-72. doi: 10.1007/978-1-4757-9209-6_33.
Combination therapy with two nucleosides has been shown to improve clinical outcome compared with zidovudine monotherapy. There is every expectation that more potent antiretroviral combination regimens will increase the clinical benefits. However, this remains to be proven definitely. The increasing number of choices of antiretroviral therapies create new challenges for those studying and those using these therapies.
与齐多夫定单药治疗相比,两种核苷联合治疗已显示出能改善临床疗效。人们完全期望更有效的抗逆转录病毒联合治疗方案将增加临床益处。然而,这仍有待明确证实。抗逆转录病毒治疗方法选择的不断增加,给研究这些疗法的人员和使用这些疗法的人员带来了新的挑战。